Overview
Aisa Pharma is a clinical stage pharma development company planning clinical trials with a new oral therapeutic agent for patients with Raynaud’s Disease, a condition that affects as many as 25 million Americans, for which no treatment has been specifically approved by the FDA.
Company News
